Lisa Carey
Chief Tech/Sci/R&D Officer at ATYR PHARMA, INC.
Network origin in Lisa Carey first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 38 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lisa Carey via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| The Salk Institute for Biological Studies | College/University | Director/Board Member | |
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Biotechnology | Founder Director/Board Member Corporate Officer/Principal Human Resources Officer | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Founder Chairman Director/Board Member | |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Other | Founder Founder Director of Finance/CFO | |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Cooley LLP engages in the provision of legal services. It offers strategic litigation and business transaction services and is a representative of private and public companies, financial institutions, venture capital firms and nonprofit organizations. Its practices include commercial litigation; patent counseling and prosecution; employment and labor; asset recovery; and estate planning and personal representation. The company was founded in 1920 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California San Diego | College/University | Corporate Officer/Principal Undergraduate Degree | |
| FATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder | |
| San Diego State University | College/University | Graduate Degree Undergraduate Degree | |
OcuNexus Therapeutics, Inc.
 OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Founder | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Analyst Private Equity Investor | |
CHP Management, Inc.
 CHP Management, Inc. Investment ManagersFinance CHP Management Inc (Cardinal Partners) is a venture capital firm founded in 1996 by John K Clarke, Brandon H Hull and John J Park. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor Founder | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| VOLCANO CORPORATION | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
CoDa Therapeutics (NZ) Ltd.
 CoDa Therapeutics (NZ) Ltd. Pharmaceuticals: MajorHealth Technology CoDa Therapeutics (NZ) Ltd. develops and markets biopharmaceutical products. The company was founded by David Becker, Colin Green, Bradford J, Duft, and Howard E. Greene and on December 9, 2003 and is headquartered in Auckland, New Zealand. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| The University of Sheffield | College/University | Doctorate Degree Doctorate Degree | |
| University of Birmingham | College/University | Undergraduate Degree Undergraduate Degree | |
| ANAPTYSBIO, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Harvard College | College/University | Undergraduate Degree | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| GLYCOMIMETICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director/Board Member | |
CANbridge Life Sciences Ltd.
 CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Jewish Federation of Omaha, Inc.
 Jewish Federation of Omaha, Inc. Miscellaneous Commercial ServicesCommercial Services Jewish Federation of Omaha, Inc. offers social, educational and cultural programs through fundraising. It supports communal services in the Omaha area by establishing and accumulating assets for permanent funding resources. The company was founded in 1903 and is headquartered in Omaha, NE. | Miscellaneous Commercial Services | Director/Board Member | |
Mavupharma, Inc.
 Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 45 |
| United Kingdom | 3 |
| Spain | 2 |
| New Zealand | 2 |
| China | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 12 |
| Commercial Services | 9 |
| Finance | 4 |
| Health Services | 3 |
Operational
| Director/Board Member | 220 |
| Corporate Officer/Principal | 101 |
| Independent Dir/Board Member | 67 |
| Founder | 38 |
| Undergraduate Degree | 36 |
Most connected contacts
| Insiders | |
|---|---|
| Srini Akkaraju Akkaraju | 54 |
| James Blair | 48 |
| Richard Heyman | 33 |
| Paul Schimmel | 31 |
| John Clarke | 30 |
| Kathryn Falberg | 30 |
| John Mendlein | 27 |
| Jeffrey Hatfield | 18 |
| Mark Goldberg | 17 |
| Frédéric Chéreau | 17 |
| David Weiner | 14 |
| Sanuj K. Ravindran | 13 |
| Jill Broadfoot | 12 |
| John McKew | 11 |
| Sara Zaknoen | 11 |
- Stock Market
- Insiders
- Lisa Carey
- Company connections
